Mark Gaffney – Chief Executive Officer

Mark has 20+ years of leadership experience in biotech & life sciences. He is motivated to find durable and safe treatments for blindness, influenced by his father’s retinitis pigmentosa. A former U.S. Air Force intelligence officer, Mark’s analytical problem-solving approach is backed by degrees in mechanical engineering and law. His dedication to innovation aims to …

Mark Gaffney – Chief Executive Officer Read More »

Tassos Konstantinou Director

Tassos is an investment manager at IP Group and specializes in early stage investing in the life science sector. Before joining IP Group, Tassos was a business development executive at CRUK Commercial Partnerships (formerly CRT) where he led the intellectual property sourcing, licensing, and spin-out creation of CRUK-funded technologies. He has experience in technology transfer …

Tassos Konstantinou Director Read More »

Geert-Jan Mulder, MD

Geert-Jan is Managing Partner at Forbion and has a leading role in the firm’s investment team and portfolio. He is an experienced life sciences investor who is led Forbion’s successful investments and served on the Boards of several Forbion portfolio companies, sometimes also in an executive capacity. In addition to his portfolio management activities, he …

Geert-Jan Mulder, MD Read More »

Professor Marc de Smet Senior Medical Advisor

Marc is Oxular’s Senior Medical Advisor and a practicing vitreoretinal surgeon, with more than 30 years of experience in ophthalmic drug and medical device development. Previously, he was the National Eye Institute’s representative responsible for defining the clinical trial of Foscarnet, the first approved drug to treat CMV retinitis in AIDS patients. He initiated the …

Professor Marc de Smet Senior Medical Advisor Read More »

V-Bio Ventures

V-Bio Ventures finds, builds, and finances innovative life sciences companies. The company invests throughout Europe in start-up and early-stage companies with high growth potential as well as in technologies that provide transformational improvements in biopharmaceutical, pharmaceutical, and diagnostics markets. V-Bio Ventures works closely with Belgium-based VIB, one of the world’s premier life science institutes, with …

V-Bio Ventures Read More »


Rosetta is a specialist UK-based life science venture capital firm that invests globally to build leading healthcare companies and breakthrough technologies that can deliver benefits to human lives. We invest through direct secondary transactions to provide flexible liquidity solutions to investors or corporations

IP Group

IP Group is a leading intellectual property commercialization company. It focuses on evolving great ideas, from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas – and the resulting businesses – by providing access to business-building expertise, capital (through its 100%-owned, FCA-authorized subsidiaries: IP Capital and Parkwalk …

IP Group Read More »


Forbion is a leading European venture capital firm that helps companies bridge research and development through the team’s expertize in drug development and company building. Forbion is signatory to the United Nations Principles for Responsible Investment, further demonstrating its philosophy that investments in companies should positively impact the health and wellbeing of patients. It currently …

Forbion Read More »

Scroll to Top